PDS Biotechnology
PDSB
52 hedge funds and large institutions have $6.94M invested in PDS Biotechnology in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 12 closing their positions.
1,108% more call options, than puts
Call options by funds: $157K | Put options by funds: $13K
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
0.42% less ownership
Funds ownership: 11.79% → 11.37% (-0.42%)
9% less funds holding
Funds holding: 57 → 52 (-5)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
58% less capital invested
Capital invested by funds: $16.6M → $6.94M (-$9.64M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$298K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$279K |
| 3 |
Renaissance Technologies
New York
|
+$203K |
| 4 |
VF
Virtu Financial
New York
|
+$145K |
| 5 |
Two Sigma Investments
New York
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IWA
Inspirion Wealth Advisors
Libertyville,
Illinois
|
-$717K |
| 2 |
IGGA
Iron Gate Global Advisors
Nsl,
Utah
|
-$287K |
| 3 |
Millennium Management
New York
|
-$285K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$113K |
| 5 |
PAS
Point72 Asia (Singapore)
Singapore
|
-$85.7K |
PDSB Hedge Fund Activity: Q4 2024 in Review
52 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q4 2024, worth a combined $6.94M — down 58% from $16.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of PDSB and 8 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 17 added.
The largest buyer was Susquehanna International Group, adding an estimated $298K. The largest seller was Inspirion Wealth Advisors, cutting an estimated $717K.
- 52 institutional investors held PDS Biotechnology (PDSB) as of Q4 2024, down from 57 in Q3 2024.
- Funds reported $6.94M of PDS Biotechnology stock for Q4 2024, down 58% quarter-over-quarter.
- 8 funds opened new PDS Biotechnology positions in Q4 2024 and 12 closed out, a net change of -4 holders.
- The largest PDS Biotechnology buyer in Q4 2024 was Susquehanna International Group, an estimated $298K added.
- The largest PDS Biotechnology seller in Q4 2024 was Inspirion Wealth Advisors, an estimated $717K sold.
Based on aggregated 13F filings for Q4 2024.